Altern Ther Health Med 21(Suppl 3):2832 Behera J, Bala J, Nuru M, Tyagi SC, Tyagi N (2017) Homocysteine as a Pathological Biomarker for Bone Disease
This epigenetic modification suppresses SLC7A11 transcription, thereby reducing xCT expression, impairing cystine uptake, and limiting intracellular GSH synthesis, ultimately heightening neuronal vulnerability to ferroptosis (92)
Intravenously: glutathione is used for preventing anaemia in patients undergoing haemodialysis, preventing renal dysfunction after coronary bypass surgery, treating Parkinsons disease, improving blood flow and decreasing clotting in individuals with atherosclerosis, treating diabetes, and preventing toxicity of chemotherapy
SsTyrA and OiTyrA were chosen as they are located at key phylogenetic boundaries within clade I and contain residues required for cofactor binding and catalysis (Figure S2, Data S2)